The hypericom perforatom effect on anxiety

Hypiran effect on anxiety in the students who reside in dormitories

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201109277651N1

Enrollment

180

Registered

2012-02-28

Start date

2007-01-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety. Generalized anxiety disorder

Interventions

Intervention 1: Intervention group: 60 drops of Hypiran each day for 2 months. Intervention 2: Control group did not take any medicine.

Treatment - Drugs

Intervention group: 60 drops of Hypiran each day for 2 months.

Control group did not take any medicine.

Eligibility

Sex/Gender

Female

Age

19 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: who suffered anxiety; they were not pregnant or breast feeding. Furthermore they was not taking hormonal, anti-anxiety or anti depression drugs. Exclusion criteria: drug allergy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anxiety. Timepoint: Before and After the search. Method of measurement: spilberger (questionnaire).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar Erfani

Alborz University of Medical Sciences and Health Services

niloofar.erfany@yahoo.com+98 26 1221 1495

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026